U.S. market Open. Closes in 5 hours 48 minutes

PETV | PetVivo Holdings, Inc. Stock Overview

(Stock Exchange: NASDAQ)
Day's Range 0.4200 - 0.4710
52 Week Range 0.2900 - 1.5000
Beta N/A
Implied Volatility N/A
IV Rank N/A
Day's Volume 6,306
Average Volume 23,921
Shares Outstanding 20,857,200
Market Cap 8,760,024
Sector Healthcare
Industry Medical - Devices
IPO Date 2014-09-08
Valuation
Profitability
Growth
Health
P/E Ratio -0.89
Forward P/E Ratio N/A
EPS -0.47
1YR Price Target N/A
Dividend Yield N/A
Dividend Per Share N/A
Dividend ExDate N/A
Dividend PayDate N/A
Employees 20
Country USA
Website PETV
PetVivo Holdings, Inc., a biomedical device company, engages in the manufacturing, commercializing, and licensing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The company's pipeline products also include 17 therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. was founded in 2009 and is headquartered in Minneapolis, Minnesota.
PETV's peers: MODD, ECOR, EYEG, ICCM, IRIX, LOGC, NMTC, NSYS, NVNO
*Chart delayed
Analyzing fundamentals for PETV we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is very bad and Health is frighteningly weak. For more detailed analysis please see PETV Fundamentals page.

Watching at PETV technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on PETV Technicals page.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙